iBio, Inc. is focused on development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases. To accelerate achievement of our objectives, we established a research & development relationship with a leading not-for-profit translational research institution, the Fraunhofer USA Center for Molecular Biotechnology (FhCMB). The success of this relationship has substantially reduced the risk of bringing important new medical products to market and has created a unique opportunity for investors.
In The News
November 1, 2017
Daniel Eliot (right) of the Delaware Small Business Development Center works with business owners to help them get up to speed on cybersecurity. Here, he is talking with Moses Senesie, who assists SBDC with business research. Senesie is studying business …
July 26, 2017
Innovation Delaware Company to Watch: Prelude Therapeutics from a textbook or a lesson plan. “Discovery is an art,” Vaddi says. “It’s not something that’s taught.” As Vaddi’s latest business venture, Prelude Therapeutics, finds its way forward, he hopes to be …